[Effect of etmosin on biliary motility disorders in patients with ischemic heart disease].
We have studied the influence of Etmosin medication on severity of IHD clinical presentations and comprised biliary motility in 162 patients aged 26 to 60. Dynamic echocholecystography (DECG) has been applied. The obtained data suggest using Etmosin in patients with ischemic heart disease and comprised biliary motility makes for normalizing tonus of the Odi sphincter and decreasing the rate of episodes of angina pectoris, although was not found any influence of Etmosin on gall-bladder motility. The use of Etmosin enables in patients with IHD and comprised biliary motility to decrease reflex angina pectoris.
Lyzohub
V H
VH
Pliskevych
D A
DA
Nikoliuk
L S
LS
Zaval's'ka
T V
TV
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001657:Biliary Dyskinesia / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D016293:Moricizine / Q000008:administration & dosage / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D046628:Sphincter of Oddi Dysfunction / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D016896:Treatment Outcome; D014463:Ultrasonography
D000889:Anti-Arrhythmia Agents; D010276:Parasympatholytics; D016293:Moricizine